FDA finalizes drug-drug interaction guidance for therapeutic proteins
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaQuality Assurance and ControlRegulatory Intelligence/Policy